TrialArteriosclerosis, thrombosis, and vascular biology2025

Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor Therapy.

Esther Reijnders et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.